Ion Exchange (india) Ltd. · NSE:IONEXCHANG
Ion Exchange (india) — Q4 FY2023 Earnings Presentation
24 slides from Ion Exchange (india)'s earnings presentation, May 28, 2023
Slide 1: Submission of Analyst / Investor Presentation to exchanges
May 28, 2023 To To BSE Limited National Stock Exchange of India Limited The Corporate Relationship Dept. Exchange Plaza, C-1, Block- G, P.J. Towers, Dalal Street Bandra Kurla Complex, Bandra (East), Mumbai-400 001 Mumbai-400 051 Scrip Code: 500214 Scrip Code: IONEXCHANG Dear Sir/ Madam, Sub: Submiss
Slide 2: Earnings Presentation – Q4-FY23 / FY23
EARNINGS PRESENTATION – Q4-FY23 / FY23
Slide 3: Executive Summary
Executive Summary • Ion Exchange (India) Ltd (Ion Exchange), formed in 1964, is a pioneer in water, wastewater treatment & environment solutions and caters to various industries, institutions, homes & communities. • Headquartered in Mumbai, the company has seven manufacturing & assembly facilities a
Slide 4: Company Overview
Company Overview • Ion Exchange was originally formed as a subsidiary of Permutit, UK in 1964. It became a wholly owned FY23 REVENUE BREAKUP* Indian company in 1985. The company is currently in its 59th Year of operations. • The company has expanded its footprints globally and possesses a diversifie
Slide 5: Q4-FY23 / FY23 Financial Highlights
Q4-FY23 / FY23 Financial Highlights Q4-FY23 Performance (Standalone) Q4-FY23 Performance (Consolidated) INR 6,204 Mn INR 954 Mn 15.38% INR 6,475 Mn INR 1,064 Mn 16.43% Operating Income Operating EBITDA Operating EBITDA Operating Income Operating EBITDA Operating EBITDA Margins Margins INR 722 Mn 11.
Slide 6: Q4-FY23 / FY23 Operational Highlights
Q4-FY23 / FY23 Operational Highlights ENGINEERING • Strong order and enquiry flows witnessed in the 4th quarter. • Regarding Sri Lanka order, the discussions amongst all the stakeholders are moving in a positive direction and we are hopeful of project closure in FY24. • Execution of the UP Jal Nigam
Slide 7: Financial Overview
FINANCIAL OVERVIEW
Slide 8: Quarterly Standalone Financial Performance
Quarterly Standalone Financial Performance INCOME STATEMENT (INR MN) Q4-FY23 Q4-FY22 Y-o-Y Q3-FY23 Q-o-Q Operating Income 6,204 4,657 33.2% 4961 25.1% Expenses 5,250 3,875 35.5% 4,355 20.6% Operating EBITDA 954 782 22.0% 606 57.4% Operating EBITDA Margins (%) 15.38% 16.79% (141) Bps 12.22% 316 Bps D
Slide 9: Quarterly Standalone Segmental Breakup
Quarterly Standalone Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 4,436 1,432 1,460 425 515 E 2,984 V E N U E Q4-FY22 Q4-FY23 Q4-FY22 Q4-FY23 Q4-FY22 Q4-FY23 558 521 388 Q4-FY22 Q4-FY23 304 E B I (8) T (18) Q4-FY22 Q4-FY23 Q4-FY22 Q4-FY23 8
Slide 10: Annual Standalone Financial Performance
Annual Standalone Financial Performance INCOME STATEMENT (INR MN) FY23 FY22 Y-o-Y Operating Income 18,922 15,094 25.4% Expenses 16,592 13,123 26.4% Operating EBITDA 2,330 1,971 18.2% Operating EBITDA Margins (%) 12.31% 13.06% (75) Bps Depreciation 280 268 4.5% Finance Cost 64 76 (15.8)% Other Income
Slide 11: Annual Standalone Segmental Breakup
Annual Standalone Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 11,789 8,999 5,256 5,835 1,930 E 1,366 V E N U E FY22 FY23 FY22 FY23 FY22 FY23 1,427 FY22 FY23 1,010 1,125 E 939 B I T (27) FY22 FY23 FY22 FY23 (40) 10
Slide 12: Quarterly Consolidated Financial Performance
Quarterly Consolidated Financial Performance INCOME STATEMENT (INR MN) Q4-FY23 Q4-FY22 Y-o-Y Q3-FY23 Q-o-Q Operating Income 6,475 4,964 30.4% 5,121 26.4% Expenses 5,411 4,013 34.8% 4,496 20.4% Operating EBITDA 1,064 951 11.9% 625 70.2% Operating EBITDA Margins (%) 16.43% 19.16% (273) Bps 12.20% 423
Slide 13: Quarterly Consolidated Segmental Breakup
Quarterly Consolidated Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) R 4,526 515 1,515 1,640 425 E V 3,208 E N U E Q4-FY22 Q4-FY23 Q4-FY22 Q4-FY23 Q4-FY22 Q4-FY23 732 482 Q4-FY22 Q4-FY23 560 345 E B (7) I T (16) Q4-FY22 Q4-FY23 Q4-FY22 Q4-FY23 12
Slide 14: Annual Consolidated Financial Performance
Annual Consolidated Financial Performance INCOME STATEMENT (INR MN) FY23 FY22 Y-o-Y Operating Income 19,896 15,769 26.2% Expenses 17,346 13,637 27.2% Operating EBITDA 2,550 2,132 19.6% Operating EBITDA Margins (%) 12.82% 13.52% (70) Bps Depreciation 291 280 3.9% Finance Cost 92 100 (8.0)% Other Inco
Slide 15: Annual Consolidated Segmental Breakup
Annual Consolidated Segmental Breakup ENGINEERING (INR MN) CHEMICALS (INR MN) CONSUMER PRODUCTS (INR MN) 12,390 1,931 R E 5,579 6,208 1,366 9,351 V E N U E FY22 FY23 FY22 FY23 FY22 FY23 1,068 1,132 FY22 FY23 1,551 1,208 E B I T (23) FY22 FY23 FY22 FY23 (36) 14
Slide 16: Historical Financial Overview
HISTORICAL FINANCIAL OVERVIEW
Slide 17: Historical Standalone Financial Performance
Historical Standalone Financial Performance INCOME STATEMENT (INR MN) FY19 FY20 FY21 FY22 FY23 Operating Income 11,023 14,072 14,018 15,094 18,922 Expenses 10,110 12,862 12,067 13,123 16,592 Operating EBITDA 913 1,210 1,951 1,971 2,330 Operating EBITDA Margins (%) 8.28% 8.60% 13.92% 13.06% 12.31% De
Slide 18: Historical Standalone Balance Sheet
Historical Standalone Balance Sheet PARTICULARS (INR MN) FY21 FY22 FY23 PARTICULARS (INR MN) FY21 FY22 FY23 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Property, Plant and Equipment 1,421 1,389 1,645 (A) Equity Share Capital 147 147 147 (B) Capital Work-in-progress 146 201 420 (B) Ot
Slide 19: Historical Consolidated Financial Performance
Historical Consolidated Financial Performance INCOME STATEMENT (INR MN) FY19 FY20 FY21 FY22 FY23 Operating Income 11,623 14,798 14,495 15,769 19,896 Expenses 10,557 13,453 12,472 13,637 17,346 Operating EBITDA 1,066 1,345 2,023 2,132 2,550 Operating EBITDA Margins (%) 9.17% 9.09% 13.96% 13.52% 12.82
Slide 20: Historical Consolidated Balance Sheet
Historical Consolidated Balance Sheet PARTICULARS (INR MN) FY21 FY22 FY23 PARTICULARS (INR MN) FY21 FY22 FY23 EQUITIES & LIABILITIES ASSETS Equity Non-Current Assets (A) Equity Share Capital 142 142 142 (A) Property, Plant and Equipment 1,486 1,446 1,707 (B) Other Equity 4,916 6,414 8,193 (B) Capita
Slide 21: Consolidated Financial Performance
Consolidated Financial Performance REVENUES (INR MN) OPERATING EBITDA (INR MN) PAT (INR MN) 2,550 19,896 2,132 1,617 1,950 2,023 15,769 1,433 14,798 14,495 1,345 942 11,623 1,066 13.96% 13.52% 12.82% 659 9.89% 10.25% 9.80% 9.17% 9.09% 6.37% 5.67% FY19 FY20 FY21 FY22 FY23 FY19 FY20 FY21 FY22 FY23 FY1
Slide 22: Market Data (Bloomberg – ION IN, Reuters – IONX.BO)
Market Data (Bloomberg – ION IN, Reuters – IONX.BO) 1 YEAR SHARE PRICE MOVEMENT (UP TO 31st March 2023) 120% 100% 80% 60% 40% 20% 0% -20% Apr-22 May-22 Jun-22 Jul-22 Aug-22 Sep-22 Oct-22 Nov-22 Dec-22 Jan-23 Feb-23 Mar-23 Ion Exchange Sensex PRICE DATA (As on 31st March 2023) SHAREHOLDING PATTERN (A
Slide 23: Disclaimer
Disclaimer Ion Exchange (India) Limited No representation or warranty, express or implied, is made as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the information or opinions contained in this presentation. Such information and opinions are in all e
Slide 24: Thank You
THANK YOU
Ion Exchange (India) — Q4 FY2023 Earnings Presentation on 6ix